ResMed Inc. (RMD)
NYSE: RMD
· Real-Time Price · USD
279.58
2.53 (0.91%)
At close: Sep 08, 2025, 3:59 PM
279.46
-0.04%
After-hours: Sep 08, 2025, 04:31 PM EDT
ResMed Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Residential Care Software Revenue | 156.5M | 156.77M | 1.07B | 1.05B | 1.02B | 963.04M | 983.48M | 980.12M | 916.98M | 844.44M | 811.6M | 763.36M | 795.84M | 806.5M | 780.33M |
| Residential Care Software Revenue Growth | -0.18% | -85.37% | +2.12% | +3.06% | +5.69% | -2.08% | +0.34% | +6.89% | +8.59% | +4.05% | +6.32% | -4.08% | -1.32% | +3.35% | n/a |
| Sleep And Respiratory Revenue | 1.13B | 1.07B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sleep And Respiratory Revenue Growth | +5.42% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Mar 31, 2020 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combined Europe Asia And Other Markets Revenue | 376.64M | 360.43M | 361.55M | 348.52M | 324.68M | 1.14B | 350.98M | 301.72M | 683.96M | 576.58M | 585.84M | 588.55M | 876.1M | 496.72M | 518.59M | 495.3M | 483.11M | 705M | 662.2M | 651.1M | 214.4M |
| Combined Europe Asia And Other Markets Revenue Growth | +4.50% | -0.31% | +3.74% | +7.34% | -71.61% | +225.86% | +16.32% | -55.89% | +18.62% | -1.58% | -0.46% | -32.82% | +76.38% | -4.22% | +4.70% | +2.52% | -31.47% | +6.46% | +1.70% | +203.68% | n/a |
| Global Revenue | 156.5M | 156.77M | 687.47M | 669.33M | 638.36M | n/a | 629.14M | 615.26M | 266.34M | 287.93M | 309.03M | 315.46M | n/a | 272.05M | 281.42M | 256.65M | 286.35M | 470.8M | 429.9M | 421.7M | 588.3M |
| Global Revenue Growth | -0.18% | -77.20% | +2.71% | +4.85% | n/a | n/a | +2.26% | +131.01% | -7.50% | -6.83% | -2.04% | n/a | n/a | -3.33% | +9.65% | -10.37% | -39.18% | +9.51% | +1.94% | -28.32% | n/a |
| Us Canada And Latin America Revenue | 748.95M | 707.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 232.3M | 229.4M | 373.9M |
| Us Canada And Latin America Revenue Growth | +5.89% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +1.26% | -38.65% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 265.13M | 245.3M | 241.61M | 238.98M | 242.19M | 229.92M | 222.16M | 222.87M | 240.69M | 228.46M | 211.67M | 193.93M | 194.89M | 182.4M | 185.36M | 176.72M | 181.48M | 160.45M | 169.47M | 158.99M | 165.38M | 172.44M | 171.42M | 167.44M | 171.6M | 164.53M | 161.58M | 147.3M | 156.81M | 147.89M | 151.82M | 143.85M | 147.94M | 137.86M | 139.31M | 128.85M | 133.93M | 119.35M | 118.22M | 111.09M | 123.25M | 116.34M |
| Selling, General, and Administrative Revenue Growth | +8.08% | +1.53% | +1.10% | -1.32% | +5.34% | +3.49% | -0.32% | -7.40% | +5.35% | +7.93% | +9.15% | -0.49% | +6.85% | -1.60% | +4.89% | -2.63% | +13.11% | -5.32% | +6.59% | -3.87% | -4.09% | +0.59% | +2.38% | -2.42% | +4.30% | +1.83% | +9.69% | -6.06% | +6.03% | -2.58% | +5.54% | -2.77% | +7.31% | -1.04% | +8.11% | -3.79% | +12.21% | +0.96% | +6.41% | -9.86% | +5.94% | n/a |
| Research and Development Revenue | 86.44M | 83.94M | 81.37M | 79.52M | 80.86M | 77.07M | 73.88M | 75.71M | 78.14M | 76.44M | 69.87M | 63.19M | 64.32M | 66.8M | 62.51M | 59.95M | 59.88M | 55.94M | 54.94M | 54.53M | 52.52M | 51.45M | 49.94M | 48.03M | 51.14M | 47.61M | 43.11M | 38.79M | 39.66M | 37.43M | 40.64M | 37.41M | 36.71M | 35.13M | 38.19M | 34.45M | 34.38M | 28.11M | 28.97M | 27.19M | 28.52M | 27.02M |
| Research and Development Revenue Growth | +2.98% | +3.16% | +2.33% | -1.65% | +4.91% | +4.32% | -2.42% | -3.11% | +2.23% | +9.39% | +10.58% | -1.76% | -3.72% | +6.87% | +4.27% | +0.13% | +7.03% | +1.83% | +0.74% | +3.83% | +2.08% | +3.02% | +3.98% | -6.07% | +7.41% | +10.44% | +11.14% | -2.18% | +5.94% | -7.90% | +8.63% | +1.93% | +4.49% | -8.01% | +10.87% | +0.19% | +22.31% | -2.97% | +6.54% | -4.67% | +5.55% | n/a |